Ikerketa proiektua
Comparative study between an oral formulation of the phytocannabinoid derivative VCE-003.2 (EHP-102) and L-DOPA/Benserazide in Parkinson’s disease using 6-hydroxydopamine-lesioned mice
date_range
Iraupena 2022(e)ko urtarrila-(a)k 01-(e)tik 2022(e)ko abendua-(a)k 31-(e)ra izan da
(12 months)
Ikertzaileak
JOSÉ JAVIER
FERNÁNDEZ RUIZ
Arduraduna
MARÍA CONCEPCIÓN
GARCÍA GARCÍA
Arduraduna